Targeting Rare Human PCSK9 Variants for Cholesterol Treatment (2013)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 61/916,862, filed Dec 17, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,883,157 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 8,951,523 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 9,040,052 | Precision Medicine By Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 10,611,849 | Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 10,618,971 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| US 11,434,305 | Precision Medicine by Targeting Rare Human PCSK9 Variants for Cholesterol Treatment In force · High confidence | Kymab Limited | In force | High confidence | ||
| Application 17/875,720 | Human Targets Abandoned Abandoned Oct 31, 2025 | Kymab Limited | Abandoned | Abandoned Oct 31, 2025 |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Kymab Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.